NCT01878708 2017-03-06A Pilot Study of Oncaspar® + Dexamethasone in Patients With Relapsed or Refractory T-Cell LymphomaDana-Farber Cancer InstitutePhase EARLY_PHASE1 Terminated2 enrolled
NCT01403415 2015-07-10Temsirolimus, Dexamethasone, Mitoxantrone Hydrochloride, Vincristine Sulfate, and Pegaspargase in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin LymphomaNational Cancer Institute (NCI)Phase 1 Completed13 enrolled